Biotest AG
BTTAY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,743,753 | $1,737,726 | $1,793,813 | $1,689,131 |
| - Cash | $107,800 | $118,500 | $116,600 | $104,400 |
| + Debt | $597,200 | $689,800 | $574,300 | $496,300 |
| Enterprise Value | $2,233,153 | $2,309,026 | $2,251,513 | $2,081,031 |
| Revenue | $726,200 | $684,600 | $516,100 | $515,600 |
| % Growth | 6.1% | 32.6% | 0.1% | – |
| Gross Profit | $223,800 | $280,300 | $124,900 | $80,700 |
| % Margin | 30.8% | 40.9% | 24.2% | 15.7% |
| EBITDA | $120,400 | $182,200 | $24,700 | -$18,300 |
| % Margin | 16.6% | 26.6% | 4.8% | -3.5% |
| Net Income | $26,400 | $127,000 | -$31,600 | -$63,300 |
| % Margin | 3.6% | 18.6% | -6.1% | -12.3% |
| EPS Diluted | 0.36 | 1.6 | -0.4 | -0.8 |
| % Growth | -77.5% | 500% | 50% | – |
| Operating Cash Flow | $60,900 | -$2,700 | -$40,500 | $33,900 |
| Capital Expenditures | -$28,700 | -$33,400 | -$29,300 | -$18,200 |
| Free Cash Flow | $32,200 | -$36,100 | -$69,800 | $15,700 |